CARM1 and non-small cell lung carcinoma: They discovered that the knockdown of lncRNA PVT1 and CARM1, coupled with the overexpression of miR‐424‐5p, increased the radiosensitivity of NSCLC, offering new targets for NSCLC therapy [83].